A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
Public ClinicalTrials.gov record NCT02094586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Randomized, Double-blind, Placebo-Controlled 3-Lot Study in Healthy Volunteers to Assess Immunogenicity, & Acceptability of a Single-dose of Live Oral Cholera Vaccine, Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR
Study identification
- NCT ID
- NCT02094586
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bavarian Nordic
- Industry
- Enrollment
- 3,146 participants
Conditions and interventions
Conditions
Interventions
- PXVX0200 Lot A Biological
- PXVX0200 Lot B Biological
- PXVX0200 Lot C Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2014
- Primary completion
- Jan 31, 2015
- Completion
- May 31, 2015
- Last update posted
- Jun 27, 2023
2014 – 2015
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research | Mobile | Alabama | 36608 | — |
| Clinical Reseach Consortium Arizona | Phoenix | Arizona | 85004 | — |
| Avail Clinical Research | DeLand | Florida | 32720 | — |
| Miami Research Associates | Miami | Florida | 33143 | — |
| Palm Beach Research | West Palm Beach | Florida | 33409 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| Heartland Research Associates | Wichita | Kansas | 67207 | — |
| Central Kentucky Research | Lexington | Kentucky | 40509 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Boston University | Boston | Massachusetts | 02218 | — |
| Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| Clinical Research Consortium Las Vegas | Las Vegas | Nevada | 89119 | — |
| Rochester Clinical Research | Rochester | New York | 14609 | — |
| Lion Research | Norman | Oklahoma | 73069 | — |
| Coastal Carolina Research | Mt. Pleasant | South Carolina | 29464 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Jean Brown Research | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02094586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2023 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02094586 live on ClinicalTrials.gov.